[1] |
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
|
[2] |
Prat A, Parker JS, Karginova O, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer[J]. Breast Cancer Res,2010,12(5): R68.
|
[3] |
Blenkiron C, Goldstein LD, Thorne NP, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype[J]. Genome Biol, 2007, 8(10):R214.
|
[4] |
Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer[J]. Cancer Res,2005,65(16):7065-7070.
|
[5] |
Hu X, Macdonald DM, Huettner PC, et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer[J]. Gynecol Oncol,2009,114(3):457-464.
|
[6] |
Yan B, Zhao LH, Guo JT, et al. miR-429 regulation of osmotic stress transcription factor 1 (OSTF1) in tilapia during osmotic stress[J].Biochem Biophys Res Commun,2012,426(3):294-298.
|
[7] |
Hasuwa H, Ueda J, Ikawa M, et al. miR-200b and miR-429 function in mouse ovulation and are essential for female fertility[J]. Science,2013,341(6141):71-73.
|
[8] |
Nissan X, Denis JA, Saidani M, et al. miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification[J]. Dev Biol,2011,356(2):506-515.
|
[9] |
Li L, Tang J, Zhang B, et al. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4[J]. Gut,2015,64(1):156-167.
|
[10] |
Sun T, Wang C, Xing J, et al. miR-429 modulates the expression of c-myc in human gastric carcinoma cells[J]. Eur J Cancer,2011,47(17):2552-2559.
|
[11] |
Wu W, Qin Y, Li Z, et al. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia:significant up-regulation of miR-141, miR-429 and miR-7-1-3p[J]. Hum Reprod,2013,28(7):1827-1836.
|
[12] |
Snowdon J, Zhang X, Childs T, et al. The microRNA-200 family is upregulated in endometrial carcinoma[J]. PLoS One,2011,6(8): e22828.
|
[13] |
Xie P, Xu F, Cheng W, et al. Infiltration related miRNAs in bladder urothelial carcinoma [ J]. J Huazhong Univ Sci Technolog Med Sci,2012,32(4):576-580.
|
[14] |
He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation[J]. Nat Rev Genet,2004,5(7):522-531.
|
[15] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism,and function[J]. Cell,2004,116(2):281-297.
|
[16] |
Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? [J]. RNA,2005,11(12):1753-1761.
|
[17] |
Zhu W, He J, Chen D, et al. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer[J]. PLoS One, 2014, 9(2):e87780.
|
[18] |
Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer[J]. JAMA,2014,311(4):392-404.
|
[19] |
Wang Y,Li M,Zang W,et al. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma[J].Cell Oncol (Dordr),2013,36(5):385-394.
|
[20] |
Krutzfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs’ [J]. Nature, 2005,438(7068):685-689.
|
[21] |
Mees ST, Mardin WA, Wendel C, et al. EP300--a miRNAregulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas[J]. Int J Cancer,2010,126(1):114-124.
|
[22] |
Li J, Du L, Yang Y, et al. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its antiapoptotic function by targeting SOX2[J]. Cancer Lett, 2013,329(1):84-90.
|
[23] |
Sun Y,Shen S,Tang H,et al. miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis[J].OMICS,2014,18(1):54-64.
|
[24] |
Chen J,Wang L,Matyunina LV,et al. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells[J]. Gynecol Oncol,2011,121(1):200-205.
|
[25] |
Snowdon J, Zhang X, Childs T, et al. The microRNA-200 family is upregulated in endometrial carcinoma[J]. PLoS One,2011,6(8): e22828.
|